We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.73%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$143B
AUM Growth
Cap. Flow
+$142B
Cap. Flow %
99.21%
Top 10 Hldgs %
11.48%
Holding
9,755
New
9,622
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$4.11B
2
AAPL icon
Apple
AAPL
+$2.06B
3
UBS icon
UBS Group
UBS
+$1.68B
4
MSFT icon
Microsoft
MSFT
+$1.36B
5
QCOM icon
Qualcomm
QCOM
+$1.23B

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 8.76%
2 Energy 7.56%
3 Technology 7.29%
4 Healthcare 7.25%
5 Industrials 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZX
9426
DELISTED
China Zenix Auto Internatl Ltd
ZX
$2K ﹤0.01%
+1,716
New +$2.43K
PACD
9427
CALL
DELISTED
Pacific Drilling S A
PACD
$2K ﹤0.01%
+50
New +$3.21K
ACHV icon
9428
CALL
Achieve Life Sciences
ACHV
$647M
0
ACHV icon
9429
PUT
Achieve Life Sciences
ACHV
$647M
0
ARCT icon
9430
Arcturus Therapeutics
ARCT
$168M
$1K ﹤0.01%
+57
New +$1.81K
ATEC icon
9431
Alphatec Holdings
ATEC
$1.49B
$1K ﹤0.01%
+33
New +$562
ATOS icon
9432
Atossa Therapeutics
ATOS
$21.8M
0
FABC
9433
Fabric.AI Inc
FABC
$17M
0
CANF
9434
Can-Fite BioPharma American Depositary Shares
CANF
$7.03M
0
CCRD
9435
DELISTED
CoreCard
CCRD
$1K ﹤0.01%
+488
New +$628
CDXS icon
9436
Codexis
CDXS
$159M
$1K ﹤0.01%
+500
New +$1.19K
CPRX
9437
CALL
DELISTED
Catalyst Pharmaceutical
CPRX
$1K ﹤0.01%
+300
New +$823
CRF
9438
Cornerstone Total Return Fund
CRF
$1.14B
$1K ﹤0.01%
+74
New +$1.41K
DLHC icon
9439
DLH Holdings
DLHC
$71M
$1K ﹤0.01%
+501
New +$1.23K
DRRX
9440
CALL
DELISTED
DURECT Corp
DRRX
$1K ﹤0.01%
+180
New +$1.76K
FOCL
9441
CALL
EDAP TMS S.A.
FOCL
$230M
$1K ﹤0.01%
+300
New +$537
FOCL
9442
EDAP TMS S.A.
FOCL
$230M
$1K ﹤0.01%
+335
New +$599
EXEL icon
9443
PUT
Exelixis
EXEL
$14.1B
$1K ﹤0.01%
+800
New +$1.25K
GAU
9444
Galiano Gold
GAU
$468M
$1K ﹤0.01%
+554
New +$955
HL icon
9445
PUT
Hecla Mining
HL
$10B
$1K ﹤0.01%
+400
New +$990
IAU icon
9446
PUT
iShares Gold Trust
IAU
$63.8B
$1K ﹤0.01%
+50
New +$1.16K
ITP icon
9447
IT Tech Packaging
ITP
$2.82M
$1K ﹤0.01%
+52
New +$621
KLIC icon
9448
CALL
Kulicke & Soffa
KLIC
$4.62B
$1K ﹤0.01%
+100
New +$1.38K
KOPN icon
9449
Kopin
KOPN
$663M
$1K ﹤0.01%
+300
New +$1.03K
LMB icon
9450
Limbach Holdings
LMB
$833M
$1K ﹤0.01%
+100
New +$956

Similar funds

UBS Group's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for UBS Group, which disclosed 9,755 positions worth $143B. Its ten largest holdings account for 11% of the portfolio.

Its largest position is State Street SPDR S&P 500 ETF Trust: 20,431,960 shares worth $4.2B.

By sector, the portfolio is most concentrated in Financials at 8.8% of assets, followed by Energy and Technology.

  • UBS Group's largest Q4 2014 buy was State Street SPDR S&P 500 ETF Trust: 20,431,960 shares worth $4.2B.
  • UBS Group's ten largest holdings make up 11% of its $143B portfolio in Q4 2014.
  • UBS Group disclosed 9,755 positions in Q4 2014, its first 13F filing on record.

Based on UBS Group's 13F filing for Q4 2014, filed 17 Feb 2015.